ARCHIVES

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

This article is from The Cancer Letter archive.

Vol. 35 No. 28 | July 17, 2009

Download PDF Visit The Full Archive

Related Articles

AHRQ Funds Research To Reduce Medical Errors.

October 19, 2001

In Brief: NCAB To Hear NCI Staff Plans For Implementing Recommendation On Nutrition & Cancer Task Force

October 1, 1982

Ethics Commission To Continue Consideration Of Compensation For Injured Research Subjects

June 20, 1980

GAO Report To Include Some But Not all Of Obey’s Charges

June 24, 1977

Solomon Gard’s Questions/Answers

January 2, 1981

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998